Why Biden's strategy to prepare U.S. for future pandemics is 'underwhelming'


Earlier this month, the White House unveiled a new strategy aimed at preparing for future pandemics. The plan costs $65 billion over the next 10 years, and allocates a significant portion of those funds to developing technology that can quickly produce vaccines, antiviral drugs, and diagnostic tests.
It sounds like a promising start, but some experts aren't all that excited about it. "It's underwhelming," Mike Osterholm, an epidemiologist at the University of Minnesota, told The Atlantic's Ed Yong. "That $65 billion should have been a down payment, not the entire program. It's a rounding error for our federal budget, and yet our entire existence going forward depends on this."
Meanwhile, Alexandra Phelan, an expert on international law and global health policy at Georgetown University, told Yong that it's the way the funds are distributed that's concerning. "We're so focused on these high-tech solutions because they appear to be what a high-income country would do," she said.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Instead, Yong writes, there's a case to be made that turning America's public health sector into a much more robust operation is just as essential as gearing up to produce vaccines. That means giving communities more money to hire and train more workers and improve their workplace infrastructure; it's not enough to simply react to emergencies in the future. Finally, there likely needs to be a greater effort to address the issues that make certain communities more vulnerable to public health crises than others — that could include increased paid sick leave, safe public housing, and food assistance, Yong writes.
For what it's worth, Eric Lander, the director of the Office of Science and Technology Policy and Biden's science adviser, agrees that the $65 billion plan isn't enough. "Nobody should read that plan as the limit of what needs to be done," he told Yong. "I have no disagreement that a major effort and very substantial funding are needed." Read more at The Atlantic.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Peter Mandelson called Epstein his 'best pal' in birthday note
Speed Read The UK's ambassador to Washington described the late convicted paedophile as an 'intelligent, sharp-witted man'
-
A Spinal Tap reunion, Thomas Pynchon by way of Paul Thomas Anderson and a harrowing Stephen King adaptation in September movies
the week recommends This month's new releases include 'Spinal Tap II,' 'One Battle After Another' and 'The Long Walk'
-
'Vampire energy' could be causing your electric bill to rise
Under the Radar Wasted energy could account for up to 10% of home use
-
Quit-smoking ads are being put out
Under the radar The dissolution of a government-funded campaign could lead to more smokers in the future
-
Sloth fever shows no signs of slowing down
The explainer The vector-borne illness is expanding its range
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Forever chemicals were found in reusable menstrual products. That is nothing new for women.
Under the Radar Toxic chemicals are all too common in such products
-
Not just a number: how aging rates vary by country
The explainer Inequality is a key factor
-
Children's health has declined in the US
The Explainer It's likely a sign of larger systemic issues
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy